Dr Salamah is the founder and Chief Executive Officer of the Human Health Education and Research Foundation (HHERF), a global organization on a mission to achieve Universal Health Coverage (UHC). HHERF builds on the power of multi-sectoral collaboration to achieve equity in access and quality of care while alleviating the financial risks on individuals caused by health expenditure.
The significant health challenges and inequalities brought upon by the Covid-19 pandemic made Dr. Salamah leave his very successful corporate career to support the development of resilient health and care systems in developing countries. Driven by his passion for humanity, innovative mindset, and long experience, he significantly contributes to making health and cares a human right rather than an industry.
Over two decades, Dr. Salamah has been recognized as one of the few international and health leaders bringing vast experience from various sectors, including but not limited to public health, quality, accreditation, pharma and medical devices, and health financing, as well as business development.
In his most recent role, he was the International Manager of the Joint Commission International (JCI), overseeing 74 countries across Africa, the Middle East, Europe, and Asia. In his capacity, he worked closely with healthcare organizations, ministries of health, governments and international aid agencies, leading academic medical centers and hospitals, healthcare leaders, and other organizations to build, manage, sustain, and improve health systems as well as quality and patient safety. In this role, Dr. Salamah developed and overlooked the new strategy of the Comprehensive Cancer Center in Muscat, Oman – a project commissioned to become the largest cancer hospital in the Gulf Region.
He also built the training model for the quality professionals within the Ministry of Health of Saudi Arabia and digitized the assessment for trainees based on competencies. Being a recognized leader in health excellence, he participated in the reform of HAMAD medical corporation in Qatar to accredit all HMC hospitals and increase the quality of care including patient safety and satisfaction.
Dr. Salamah spent more than 18 years in healthcare business development within multinational corporations like Pfizer, Novo Nordisk, Eli Lilly Suisse, and Johnson & Johnson and advised many other big multinational corporations across five continents.
Before working with the JCI, he was the Chief Executive Officer of a leading Healthcare Consultancy Firm, overseeing and developing technical, marketing, and financial feasibility studies for healthcare projects. In his role, he worked with public and private clients in 58 countries and led projects with budgets of over $2 billion.
Prior he led one of the leading pharma and medical supply companies in the UAE. In this capacity, he managed a portfolio of 400 products, more than 2000 SKUs, and a budget of 110 Million USD.